- Adherence
- Children
- The management of childhood pneumonia in settings with a high burden of HIV (part 1) - 16/5/2008
- The management of childhood pneumonia, part 2, 16/5/2008
- Early infant HIV diagnosis (31/1/08)
- Audit of high infant mortality in Durban hospitals illustrates delivery gap remaining for PMTCT and paediatric ART programmes - 12/6/2007
- HIV treatment for mothers and children in Botswana: lessons from a dynamic programme - 20/10/2006
- Improving access to appropriate paediatric antiretroviral formulations - 27/10/2005
- Children with HIV are being left behind in the rollout of antiretroviral therapy - 27/10/2005
- Cotrimoxazole study opens door to new public health programmes targeting all children with HIV - 27/10/2005
- Isoniazid prophylaxis treatment for children with HIV: is it ready for implementation? - 27/10/2005
- Clinical reviews
- Drug supply
- Guidelines
- Hepatitis and HIV coinfection
- HIV Testing
- Infant feeding
- Laboratory monitoring
- Malaria & HIV
- Neurological problems, including HIV dementia
- Nutrition
- Palliative care
- Prevention
- Prevention of mother-to child transmission
- Scaling up treatment and models of service delivery
- Side-effects
- South Africa
- Starting treatment
- Stigma
- Treatment failure
- Tuberculosis
- Viral load testing
Children
The management of childhood pneumonia in settings with a high burden of HIV (part 1) - 16/5/2008
The management of childhood pneumonia, part 2, 16/5/2008
Early infant HIV diagnosis (31/1/08)
Audit of high infant mortality in Durban hospitals illustrates delivery gap remaining for PMTCT and paediatric ART programmes - 12/6/2007
HIV treatment for mothers and children in Botswana: lessons from a dynamic programme - 20/10/2006
Improving access to appropriate paediatric antiretroviral formulations - 27/10/2005
Children with HIV are being left behind in the rollout of antiretroviral therapy - 27/10/2005
Cotrimoxazole study opens door to new public health programmes targeting all children with HIV - 27/10/2005
Isoniazid prophylaxis treatment for children with HIV: is it ready for implementation? - 27/10/2005
About HATIP
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.
Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.
Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.
latest aidsmap news
- Microbicide and PrEP potential for anal sex explored further in monkey studies
- ‘Shocking’ rates of adverse events seen with traditional and medical circumcision in Kenya
- Brazil rejects tenofovir patent
- Fibrosis linked to rapid loss of gut CD4 cells after HIV infection
- Poor results using non-medical HIV counsellors to screen for treatment eligibility in Malawi
- Raltegravir may cause temporary worsening of pre-existing depression
- Etravirine (<i>Intelence</i>) approved in Europe for treatment-experienced patients
- Belief in conspiracy theories means less HIV testing in South Africa
- Case report - viral load undetectable in blood, but detectable in semen
- Blood viral load predicts HIV transmission better than semen viral load in small study among MSM